Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001193125-26-002367

Options or other derivatives

  • Director acquired 643 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Ferrante Karen Jean · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +643 643 D
Loading xslF345X05/ownership.xml…